𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma prolactin and its relationship to risk factors in human breast cancer

✍ Scribed by H. G. Kwa; F. Cleton; M. De Jong-Bakker; R. D. Bulbrook; D. Y. Wang; J. L. Hayward

Publisher
John Wiley and Sons
Year
1976
Tongue
French
Weight
460 KB
Volume
17
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The prolactin concentration has been determined in plasma from ostensibly healthy women living on the Island of Guernsey. There were 102, 42 and 41 women who had a mother, sister or maternal aunt, respectively, with breast cancer. The remaining 184 women in this study claimed to have no known family history of breast cancer and were used as a control group. The increased risk of breast cancer due to familial history was not associated with a raised mean prolactin level compared to the control group. However, in the luteal phase of the menstrual cycle, daughters of breast cancer patients had significantly raised levels of prolactin at 19.00 h. There were no abnormalities in the mean plasma prolactin levels for the above groups associated with differences in age at first child, age at menarche, interval between age at menarche and first child, and body weight of post‐menopausal women. (All these factors have been reported to influence breast cancer risk). It is concluded that prolactin has no obvious function in the aetiology of breast cancer. If it is involved, the mechanism by which it acts must be subtle and concerned with the homeostatic control governing nycthemeral prolactin rhythms.

πŸ“œ SIMILAR VOLUMES

Nyctohemeral changes in plasma prolactin
Nyctohemeral changes in plasma prolactin levels and their relationship to breast cancer risk
✍ D. Y. Wang; H. E. Sturzaker; H. G. Kwa; F. Verhofstad; J. L. Hayward; R. D. Bulb πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 French βš– 356 KB

## Abstract The amount of prolactin has been determined in serial blood samples taken over 24 h from 20 pre‐ and 9 post‐menopausal women volunteers. All women had a large increase in prolactin at night (24.00 h‐03.00 h). A much smaller rise in prolactin occurred in the evening (18.00 h‐20.00 h) whi

Plasma prolactin levels and age in a fem
Plasma prolactin levels and age in a female population: Relation to breast cancer
✍ R. D. Bulbrook; D. Y. Wang; J. L. Hayward; H. G. Kwa; F. Cleton πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 French βš– 277 KB

## Abstract Plasma prolactin levels have been measured in over 4,000 normal women. The relation between hormone levels and age fits a cubic equation. It is suggested that a curve of this nature would generate the observed ageincidence curve for breast cancer, if prolactin were a carcinogen or promo

Reproductive factors and family history
Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women
✍ A. Heather Eliassen; Shelley S. Tworoger; Susan E. Hankinson πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 91 KB πŸ‘ 1 views

## Abstract Many reproductive factors are associated with breast cancer risk, potentially through a hormonal pathway. The peptide hormone prolactin is essential in mammary development and lactation and may be a link between risk factors and breast cancer. While higher prolactin levels are associate

Human relevance of rodent prolactin-indu
Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments
✍ Philip W. Harvey πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 64 KB πŸ‘ 1 views

Prolactin-induced mammary carcinogenesis in rodents, particularly rats, is often stated to be of low toxicological relevance to humans. This opinion appears to have developed from a number of lines of cited evidence. Firstly, there had been long experience of use of dopamine antagonists (that increa